LFG
AVEO

Larson Financial Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Larson Financial Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-566
Closed -$4K – 1443
2022
Q2 		$4K Hold
566
– – ﹤0.01% 931
2022
Q1 		$3K Hold
566
– – ﹤0.01% 891
2021
Q4 		$3K Hold
566
– – ﹤0.01% 926
2021
Q3 		$3K Hold
566
– – ﹤0.01% 766
2021
Q2 		$4K Hold
566
– – ﹤0.01% 671
2021
Q1 		$4K Hold
566
– – ﹤0.01% 659
2020
Q4 		$3K Hold
566
– – ﹤0.01% 621
2020
Q3 		$3K Sell
566
-1,881
-77% -$9.31K ﹤0.01% 581
2020
Q2 		$13K Hold
2,447
– – 0.01% 350
2020
Q1 		$9K Sell
2,447
-1
-0% -$5 0.01% 311
2019
Q4 		$15K Sell
2,448
-200
-8% -$1.47K 0.01% 261
2019
Q3 		$22K Buy
2,648
+981
+59% +$7.3K 0.01% 208
2019
Q2 		$11K Buy
1,667
+1,100
+194% +$9.42K 0.01% 243
2019
Q1 		$5K Hold
567
– – ﹤0.01% 307
2018
Q4 		$9K Buy
+567
New +$12.5K 0.01% 237

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Larson Financial Group's AVEO Position: Q3 2022 in Review

Larson Financial Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2022, closing a stake of 566 shares — an estimated $4K sold.

Larson Financial Group first reported a position in AVEO in Q4 2018 and held it in 15 quarters. The position peaked at $22K in Q3 2019. 77 funds tracked by Wall St. Rank hold AVEO as of Q3 2022.

  • Larson Financial Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • Larson Financial Group sold 566 AVEO Pharmaceuticals, Inc. shares in Q3 2022, an estimated $4K.
  • Larson Financial Group first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2018 and held it in 15 quarters.
  • Larson Financial Group's AVEO Pharmaceuticals, Inc. position peaked at $22K in Q3 2019.
  • 77 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2022.

Based on Larson Financial Group's 13F filing for Q3 2022, filed 3 Nov 2022.